Vertex Pharmaceuticals (VRTX)

Add to Watchlists
Create an Alert
106.17 -1.99  -1.84% NASDAQ Oct 22, 8:00PM BATS Real time Currency in USD

Vertex Pharmaceuticals Total Liabilities (Quarterly):

945.55M for June 30, 2014

View 4,000+ financial data types

View Full Chart

Vertex Pharmaceuticals Total Liabilities (Quarterly) Chart

Export Data
Save Image

Vertex Pharmaceuticals Historical Total Liabilities (Quarterly) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 945.55M
March 31, 2014 966.23M
Dec. 31, 2013 962.64M
Sept. 30, 2013 1.318B
June 30, 2013 1.262B
March 31, 2013 1.646B
Dec. 31, 2012 1.760B
Sept. 30, 2012 1.691B
June 30, 2012 1.567B
March 31, 2012 1.415B
Dec. 31, 2011 1.417B
Sept. 30, 2011 1.512B
June 30, 2011 1.456B
March 31, 2011 1.147B
Dec. 31, 2010 1.221B
Sept. 30, 2010 1.239B
June 30, 2010 827.07M
March 31, 2010 779.69M
Dec. 31, 2009 859.14M
Sept. 30, 2009 964.75M
June 30, 2009 710.82M
March 31, 2009 859.03M
Dec. 31, 2008 741.60M
Sept. 30, 2008 717.66M
June 30, 2008 730.88M
   
March 31, 2008 585.25M
Dec. 31, 2007 330.18M
Sept. 30, 2007 323.11M
June 30, 2007 346.48M
March 31, 2007 333.80M
Dec. 31, 2006 415.64M
Sept. 30, 2006 394.34M
June 30, 2006 450.48M
March 31, 2006 291.75M
Dec. 31, 2005 309.82M
Sept. 30, 2005 417.26M
June 30, 2005 473.94M
March 31, 2005 492.72M
Dec. 31, 2004 510.01M
Sept. 30, 2004 500.04M
June 30, 2004 513.76M
March 31, 2004 512.09M
Dec. 31, 2003 531.57M
Sept. 30, 2003 511.39M
June 30, 2003 473.94M
March 31, 2003 440.04M
Dec. 31, 2002 437.14M
Sept. 30, 2002 422.86M
June 30, 2002 423.79M
March 31, 2002 425.40M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Get data for
Advertisement

VRTX Total Liabilities (Quarterly) Benchmarks

Companies
Gilead Sciences 15.12B
Regeneron Pharmaceuticals 1.087B
Amgen 45.15B

VRTX Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 779.69M Mar 2010
Maximum 1.760B Dec 2012
Average 1.263B

VRTX Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("VRTX", "liabilities")
  • Last 5 data points: =YCS("VRTX", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.